Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Heidelberg University

Germany · Europe · Gold

★ Sector Awards 2026. Finalist: the Pharmaceuticals and Therapeutics Award (with Boehringer Ingelheim; Bernhard Karl Krämer and Michaela Mattheus).

#154World rank of 1,038
71.6ICI scoreout of 100
#11National rank, of 57 in Germany
#71Regional rank, of 388 in Europe
2,875.5Verified industry works, 2021 to 2025
929Company groups worked with (327 on two or more works)

Heidelberg University is ranked #154 of 1,038, with Gold standing. Its strongest pillar is scale (93): a network of 327 company groups on two or more joint works. It is held back most by breadth (14): partners concentrated in a few research fields.

Research Collaboration Index 2026: #66 of 1,195, Platinum standing · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
74

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 2,875.5 verified works against about 2,245 expected for its fields (1.28 times the expected rate).

Durability20% of the score
92

How much of its industry work sits in sustained partnerships with the same company group. 99 sustained partnerships: five or more joint works in at least three of the five years, not counting consortium papers or works on which every author from the company also holds a post at the university.

Scale30% of the score
93

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 327 company groups on two or more joint works; 99 sustained partnerships.

Breadth20% of the score
14

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (71.6) is the weighted average of the four percentiles. Rank 154 of 1,038 overall; 11 of 57 in Germany; 71 of 388 in Europe. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

5.6%of its 51,163 research works in 2021 to 2025 were co-authored with a verified company
1.28Industry co-authorship rate: 1.28 times what its mix of research fields would predict (2,875.5 verified works; about 2,245 expected)
99sustained partnerships: the same company group on five or more joint works in at least three of the five years, not counting consortium papers or works on which every author from the company also holds a post at the university

In Germany

11 of 57 ranked universities in Germany

  1. #9 Johannes Gutenberg University Mainz world #119, score 73.9
  2. #10 Karlsruhe Institute of Technology world #150, score 71.7
  3. #11 Heidelberg University world #154, score 71.6
  4. #12 Christian-Albrechts-Universität zu Kiel world #195, score 69.2
  5. #13 Medizinische Hochschule Hannover world #197, score 69.1

All ranked universities →   Europe: 71 of 388 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#13 of 323Medical Technology and Digital Health191.5 verified works in the sector
#10 of 220Biotechnology and Advanced Therapies129 verified works in the sector
#29 of 638Pharmaceuticals and Therapeutics737.5 verified works in the sector
Pharmaceuticals and Therapeutics
737.5#29 of 638
Medical Technology and Digital Health
191.5#13 of 323
Biotechnology and Advanced Therapies
129#10 of 220
Artificial Intelligence
46#114 of 292
Climate, Environment and Sustainability
20not ranked: under 20 works as the sector index counts them
Advanced Materials and Nanotechnology
12under 20 works
Software, Cloud and Data
12under 20 works
Semiconductors and Microelectronics
8under 20 works
Chemicals, Process and Resources
7.5under 20 works
Quantum Technologies
6.5under 20 works
Clean Energy Transition
6under 20 works
Agriculture and Food Technology
3.5under 20 works
Robotics and Autonomous Systems
3ranking withheld (under 10 eligible)
Advanced Manufacturing and Industry 4.0
2under 20 works
Space and Satellite Technology
1under 20 works
Not in any of the 21 sectors
1,686counted in the overall index

A sector marked “under 20 works as the sector index counts them” shows 20 or more works here but is not ranked: the sector ranking counts each work at the weight of one of its company links, so a work counts half there when that company's authors also hold a post at the university, even if another company's author does not. On that count the university has fewer than 20 works in the sector.

1,189.5 of its 2,875.5 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Heidelberg University co-authored verified work with 929 company groups, consortium papers aside: 327 of them on two or more works, and 99 as sustained partners.

The largest 12 of its 929 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
Boehringer IngelheimSUSTAINEDGermanyMedicine180.55 of 5
RocheSUSTAINEDSwitzerlandMedicine168.55 of 5
Johnson & JohnsonSUSTAINEDUnited StatesMedicine133.55 of 5
NovartisSUSTAINEDSwitzerlandMedicine1205 of 5
AstraZenecaSUSTAINEDUnited KingdomMedicine91.55 of 5
BayerSUSTAINEDGermanyMedicine905 of 5
Siemens HealthineersSUSTAINEDGermanyMedicine815 of 5
SynlabSUSTAINEDGermanyMedicine705 of 5
PfizerSUSTAINEDUnited StatesMedicine62.55 of 5
Bristol-Myers SquibbSUSTAINEDUnited StatesMedicine615 of 5
Merck KGaASUSTAINEDGermanyMedicine575 of 5
Munich Leukemia LaboratorySUSTAINEDGermanyMedicine515 of 5

SUSTAINED marks a sustained partnership: five or more joint works in at least three of the five years, not counting consortium papers or works on which every author from the company also holds a post at the university. 12 of its 99 sustained partnerships are in this table; the other 87 are with company groups not listed here.

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

5942021
5972022
5782023
540.52024
5662025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

7 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT07253727 The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting with Olympus Europe SE & Co. KG, 2025
  • NCT07798674 TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias with Horizon Europe, 2024
  • NCT06216158 Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma with Sanofi, 2024
  • NCT05804032 Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma with Sanofi, 2023
  • NCT05695508 GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 with Janssen Research & Development, LLC, 2022
  • NCT05339087 Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH with Merck Sharp & Dohme LLC, 2022

Funded partnerships (reported, not scored)

Publicly funded research projects with companies

European Union: 88 Horizon projects with company partners

Horizon 2020 and Horizon Europe projects starting 2021 to 2025 in which this university and at least one company take part (328 distinct companies). Most frequent: Ospedale San Raffaele Srl; Nurogames GmbH; Accelopment Schweiz AG; Insel Gruppe AG; Concentris Research Management GmbH; Intesa Sanpaolo SpA.

  • ERDERA EUROPEAN RARE DISEASES RESEARCH ALLIANCE 2024, 20 companies
  • EBRAINS 2.0 EBRAINS 2.0: A Research Infrastructure to Advance Neuroscience and Brain Health 2024, 3 companies
  • UNCAN-Connect UNCAN-CONNECT: Decentralized Collaborative Network for Advancing Cancer Research and Innovation 2025, 10 companies

Shown for context from the public grant registries; they do not enter the score in Edition 1. Company partners are listed as the registry records them, so a registry can list as a company an organisation that the index itself does not count as industry. Comparable open registries of company partners exist for the European Union and the United Kingdom but not yet for most other research systems, and in some countries national research organisations take part on behalf of university laboratories, so these counts are not comparable between countries.

Funded and co-publishing. Of the funded company partners that match an ICI company group, 27 also appear in this university's verified co-authorship record (AstraZeneca; Miltenyi Biotec; Concentris; Boehringer Ingelheim; Johnson & Johnson; Novartis) and 66 are funded partners not yet visible in it. About 30% of funded company names could be matched to a company group; the rest are counted, not guessed. Sources: UKRI Gateway to Research harvested 4 Oct 2026; CORDIS bulk files of 2026-10-12 (latest record update 2026-06-10). Funded partnerships cover UK (UKRI Gateway to Research) and EU (Horizon 2020 and Horizon Europe, CORDIS) projects starting 2021 to 2025 only. They are reported, never scored, and a funder record outside these two sources is not visible here.

Evidence checked

4,387 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 4,855 of 9,242 candidate links were set aside.

Why links were set aside
  • 2,612 company name not written in the author's affiliation
  • 477 ordinary-word name without a company suffix
  • 426 a place or common word that failed its stricter rule
  • 346 part of a university or public institute's own unit
  • 197 excluded after hand audit (Kirchhoff): matched from the Kirchhoff Institute and street names
  • 190 the current open record no longer attributes the work to the university
  • 77 excluded after hand audit: Chan Zuckerberg Initiative and Biohub are philanthropic and non-profit research organisations
  • 76 excluded after hand audit, for 36 further organisations, each named with its published reason in the link ledger download
  • 69 excluded after hand audit (Flatiron Health): matched almost only from the Flatiron Institute, a non-profit research institute
  • 44 excluded after hand audit (Spital Thurgau): a hospital
  • 40 only inside the university's own affiliation text
  • 35 excluded after hand audit: GWT-TUD is TU Dresden's own transfer company (university-owned)
  • 33 not an industry organisation
  • 29 part of a street or district address
  • 25 excluded after hand audit: Fimlab is a laboratory company owned by public hospital districts (public healthcare)
  • 20 excluded after hand audit (Artificial Intelligence in Medicine): a WHO/ITU focus group and a hospital programme, not a company
  • 16 excluded after hand audit: CEINGE is a non-profit research consortium
  • 16 excluded after hand audit: Sciensano is the Belgian federal public health institute (government)
  • 15 excluded after hand audit (Twitter): matched from social media handles in affiliation text
  • 15 excluded after hand audit: ARUP Laboratories is wholly owned by the University of Utah; university-owned organisations are not industry
  • 14 excluded after hand audit (Fischer): matched from street names (Ernst-Otto-Fischer-Strasse)
  • 11 excluded after hand audit (Phoenix): matched from the city of Phoenix
  • 11 excluded after hand audit (Vanke): matched from the Vanke School of Public Health and a street address
  • 10 a funding or conflict-of-interest statement
  • 10 excluded after hand audit: Scripps Research is a non-profit research institute, not a company
  • 8 excluded after hand audit (Center for Clinical Research): matched from university research centre names
  • 7 a list of companies, not an address
  • 7 excluded after hand audit (Hartford Financial Services): matched from Hartford HealthCare (a hospital system) and the city of Hartford
  • 7 excluded after hand audit: ALBA Synchrotron is a publicly owned research facility
  • 6 excluded after hand audit (Medica): matched from Italian department names (Medica)
  • 6 excluded after hand audit (Victor): matched from personal names

For your communications

Badges you can use

Gold standing badgeSector Awards finalist badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where Heidelberg University's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It is now onboarding founding partner universities: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Heidelberg University ranks #66 of 1,195, with Platinum standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure on this page comes from the published record and can be checked. If a company partner is missing or should not be listed, send the evidence through the corrections page; corrections are free and are reviewed against the open scholarly record. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.